Exec has worked at Anthem and Humana
authors Geert De Lombaerde
Kidney care company Sanderling has named Stanley Crittenden its new chief medical officer.
Crittenden comes to downtown-based Sanderling after working nearly two years at Anthem, where he was national medical director of Medicare Advantage chronic special needs plans — which includes the locally based Aspire Health palliative care business Anthem bought in 2018 — and led a number of nephrology initiatives. At Sanderling, he is overseeing clinical care and strategy and focusing on value-based population health programs related to chronic kidney disease, cardio-renal syndrome and end-stage kidney disease.
Sanderling Chairman and CEO Jerome Tannenbaum told the Post he is looking for Crittenden to meld his expertise with population health models to Sanderling’s experience with telemedicine for chronic and end-state kidney disease patients. The goal, he added, is to have this group of patients, whose treatments are very expensive, use fewer emergency room and hospital resources.
Before working at Anthem, Crittenden was a corporate medical director in Humana’s health care services division and chairman of the Humana Clinical Practice Guidelines Committee. His arrival comes a few months after Tannenbaum recruited Dennis Kogod to be Sanderling’s president and build out its value-based platforms.
As CMO, Crittenden takes over from Sanderling co-founder and Senior Vice President Rajeev Prasad, who is still with the company and focused on growing its hospital-based telenephrology segment and helping nephrologists in the company’s clinics grow their practice.